379 / Protocol for Patient Isolation for Acinetobacter Baumanni Infections

SPAIN
Classification of the PSP
Type of Patient Safety Practice Not Evaluated
 
Clinical Practice (CP)
Related practices from PaSQ database
"Best fit" category of the reported practice
Infection control / Prevention of surgical site infections
There is no specified text here There is no specified text here
Topic of the reported practice
Clinical guidelines or pathways
Aim and the benefit of the Patient Safety Practice
 
A protocol for Patient Isolation and cleaning of the room was developed with the purpose to prevent/reduce/ minimise the risk of infection for patients in the X medical unit / Y medical department in the period X-Y.

Acinetobacter baumanii is a multiresistant bacteria that has produced outbreaks in the intensive care units (ICU) in Spain. A protocol for patient isolation and cleaning of the room was developed in order to prevent the risk of infection for patients in the ICU.

The protocol was developed when the first patient with Acinetobacter baumanii was admitted in our hospital ICU (in August 2012). That patient was transferred from another hospital.

During the two years that the protocol has been used in our hospital we have had neither, any outbreak of Acinetobacter baumanni nor any case of healthcare associated infection related to Acinetobacter baumanni.
Description of the Patient Safety Practice
 
When a patient with Acinetobacter baumanni (multiresistant) is detected in the hospital or is transferred from another hospital and is known to be a carrier of Acinetobacter baumanni (multiresistant) the patient is isolated.

Patient are isolated (Contact isolation). This means use of disposable coats, gloves, etc. and special hydro alcoholic solutions containing 2-butanone peroxide (eg Biostex® from Neochemical) , soap (NeostexPlus®), as well as cleaning products which contain it (eg Areastex® ) are used.

When the patient leaves the hospital, a final cleaning disinfection with aerosol is used.

FULL PROTOCOL
1.    Patient:

Contact Isolation: The patient is placed in contact isolation (disposable coat and gloves, etc). The infection control department explains the control measures to health care personnel, patient and family. The infection control department contacts the physician in charge of the patient and advises him to contact the Infectious diseases department.

When the Infectious diseases department advises to perform decolonization: The patient is bathed (using water and soap) twice a day; an antiseptic solution “Neostex Plus”1 ® (Neochemical) is applied after the bath. When the skin is very sensitive the alternative decolonization is performed with water and soap that contains 2-butanone peroxide Biostex® or a bath using water and soap with 4% clorhexidine diluted in water (50% dilution)

When acinetobacter baumanii is in nostrils: Assess the use of antibiotic ointment in nostrils or mouthwashes with Chlorhexidine solution

2.    Health care professional:
Handrubs with hydroalcoholic antiseptic solution “Neostex Plus” (Neochemical) before and after contact with patient and his environment. For sensitive skins handwash with water and soap “Biostex” (Neochemical). Contact isolation practices.

3.    Carrier cultures
If the patient with Acinetobacter baumanii was sharing a double room when detected, a carrier culture should be performed to his/her roommate. If there is an oubreak in the ICU, perform carrier culture to patients from adjoining rooms.     

A baseline measurement before implementation of the reported practice was obtained

Not relevant, because there were no cases or outbreaks of Acinetobacter baumanii before the implementation

Evaluation of a "positive" effect of the reported practice on Patient Safety

This protocol was developed when the first patient with Acinetobacter baumanii was admitted in our hospital ICU (in August 2012), transferred from another hospital

During the two years that the protocol has been used in our hospital we didn’t have any outbreak of Acinetobacter baumanni neither any case of Health Care associated Infection associated with Acinetobacter baumanni.
Attachment of relevant written information and/or photos, as appropriate
There is no specified text here
There is no specified text here
There is no specified text here
There is no specified text here
Effectiveness of the Patient Safety Practice
 
Degree of implementation of reported practice
Yes, fully
Level of implementation of reported practice
Institution level
Specific and measurable outcome for the reported practice were defined
Not relevant
A baseline measurement before implementation of the reported practice was obtained
Not relevant
A measurement after full implementation of the reported practice was obtained
Yes
Evaluation of a "positive" effect of the reported practice on Patient Safety
Not relevant
Type of before-and after evaluation
Not relevant
Enclosure of a reference or attachment in case of published evaluation's results
There is no specified text here
There is no specified text here
Health care context where the Patient Safety Practices was implemented
 
Hospital
Transferability
 
Successful implementation of this Patient Safety Practice in other health care settings than above stated
Not known
Specification of implementation in another health care setting(s)
There is no specified text here
Successful implementation's level  of this Patient Safety Practice across settings
There is no specified text here
Involved health care staff
 
Physicians
Patient Involvement
 
Direct service user's involvement as integral part of this Patient Safety Practice
No
Specification of the service users or their representatives' involvement in the implementation of this Patient Safety Practice
There is no specified text here
Point of time in which service user or their reprasentatives' involvement takes place
There is no specified text here
Active seeking of service users' opinion, feedback, experience, etc. as integral part of this Patient Safety Practice
There is no specified text here
Short description of the service users' level of involvement
There is no specified text here
Public accessibility of information regarding this Patient Safety Practice to patients and citizens/service users
No
List of sources where public information is accessible
There is no specified text here
Implementation of the Patient Safety Practice
 
Existing collaboration with other countries or international organisations related to implementation of this Patient Safety Practice
No
Problems encountering in the implememntation course of this Patient Safety Practice like lack of motivation, no management support, etc.
No
List of the most prevelent difficulties encuntered during implementation of this Patient Safety Practice
There is no specified text here
List of the most prevalent drivers for a successful implemetation of this Patient Safety Practice
Motivated staff
Use of any specific incentives to enhance motivation while implementing this Patient Safety Practice
No
Description of used incentives, if any.
There is no specified text here
Existence of support or approval by the clinical or hospital management or any other hihg level authority in the implementation process of this Patient Safety Practice
Yes
Costs of the Patient Safety Practices
 
Completion of cost calculation related to this Patient Safety Practice
No
Total number of person days required to implement this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total number of person days required for training as preparation for implementation of this Patient Safety Practice
Clinical staff: There is no specified text here
External consultants: There is no specified text here
Support staff: There is no specified text here
Managerial staff: There is no specified text here
Others: There is no specified text here
Not relevant: There is no specified text here
Total cost in Euro of specific equipment (machines, software, communications supplies, etc.) needed to support implementation of this Patient Safety Practice
There is no specified text here
Associated cost with a work reduction or foregoing in order to deliver this Patient Safety Practice
There is no specified text here
Contact information
 
Name: Francisco Guillen Grima
Country: SPAIN
Organisation: University Clinic of Navarra
E-mail: frguillen@unav.es
Phone: 34948296384
Print
Top
At la sikisen cesaretli kadina 50 cm at yarragi giriyor hayvanli porno izle
sirinevler escort sirinevler escort atakoy escort mecidiyekoy escort etiler escort atasehir escort capa escort
usak escort elazig escort
sex filme
porno
sirinevler escort beylikduzu escort atakoy escort sisli escort atakoy escort sisli escort sirinevler escort beylikduzu escort halkali escort halkali escort istanbul escort beylikduzu escort beylikduzu escort sirinevler escort sirinevler escort beylikd�z� escort �i�li escort �irinevler escort avrupa yakasi escort �apa escort beylikd�z� escort